Piscataway, NJ, April 11, 2025 –Camber Pharmaceuticals is excited to announce the addition of Lurasidone Hydrochloride Tablets.
Lurasidone Hydrochloride Tablets are an atypical antipsychotic indicated for the treatment of:
· Schizophrenia in adults and adolescents (13 to 17 years)
· Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults and pediatric patients (10 to 17 years) as monotherapy
· Depressive episode associated with Bipolar I Disorder (bipolar depression) in adults as adjunctive therapy with lithium or valproate
Lurasidone Hydrochloride Tablets in 20 mg, 40 mg, 60 mg, 80 mg, 120 mg strengths are available in 30 count bottles.
To find out more information on Lurasidone Hydrochloride Tablets, please visit: www.camberpharma.com/lurasidone
Camber Pharmaceuticals is a fully integrated pharmaceutical company. Its parent company, Hetero, of Hyderabad, India, is one of the world’s leading API and finished dose manufacturers. Camber is committed to bringing the highest quality generic pharmaceuticals to consumers and improving quality of life through cost-effective medications.
